Report 2019- Immunoassay Market Analysis by Size, Growth, Share, Opportunities and Competitive Analysis Improving Clinical Outcomes In-depth Research to 2023
Jan 8, 2019
Immunoassay: The rising prevalence of chronic conditions is projected to boost the market growth at a healthy CAGR of ~ 8.5%
Pune, India - January 7, 2019 /MarketersMedia/ —
Immunoassay Market Highlights
Immunoassay is widely used in significant areas of pharmaceutical analysis which include diagnosis of diseases and in therapeutic drug monitoring.
A number of factors such as the increasing prevalence of chronic conditions, growth in the biotechnology and pharmaceutical sector, increasing adoption of rental immunoassay analyzers, rising use of immunoassay in oncology, growing awareness about immunoassay, healthcare insurance coverage for various infectious diseases, unmet medical needs, improving regulatory framework, and increasing government assistance are propelling the growth of the global immunoassay market.
It is estimated that the immunoassay market is expected to grow at a CAGR of 8.5% during the forecast period of 2017–2023.
However, stringent FDA regulations, lack of specificity, the complex procedure of testing, and poor healthcare system in low- and middle-income countries may hamper the growth of the market.
Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/5841
Industry Segmentation
The global immunoassay market is segmented on the basis of product and service, type, and end-user.
On the basis of product and service, the market is classified as reagents and kits, analyzers, and software and services. The reagents and kits segment is classified as Enzyme-Linked Immunosorbent Assay (ELISA) reagents and kits, rapid test reagents and kits, western blot reagents and kits, elispot reagents and kits, RIA reagents and kits, and PCR reagents and kits. The analyzers segment is classified as portable analyzers and benchtop analyzers.
On the basis of type, the market is classified as Radioimmunoassay (RIA), Counting Immunoassay (CIA), Enzyme Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoroimmunoassay (FIA), and Chemiluminescence Immunoassay (CLIA).
On the basis of application, the market is classified as infectious diseases, oncology, autoimmune disorders, toxicology, neonatal screening, cardiology, hematology and blood screening, bone and mineral disorders, and others.
On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic laboratories, research and academic laboratories, pharmaceutical companies, biotechnology companies, and others.
Competitive Analysis by Major Key Players
Some of key the players in the global immunoassay treatment market are Beckman Coulter, Inc., Abbott Laboratories, Radiometer, Alere, Arlington Scientific, Bio-Rad Laboratories, BioMerieux, Inc., DiaSorin, Diamedix, Dynex Technologies, Fujirebio US, Gold Standard Diagnostics, Hycor Biomedical, Inova Diagnostics, Ortho-Clinical Diagnostics, Randox Toxicology, F. Hoffmann-La Roche Ltd., Siemens Healthineers, ThermoFisher Scientific, TOSOH Bioscience, Wako Diagnostics, Shenzhen New Industries Biomedical Engineering Co., Ltd., Sysmex Corporation, and others.
Intended Audience
Pharmaceutical Companies
Medical Device Companies
Research and Development (R&D) Companies
Diagnostic Laboratories
Government Research Institute
Academic Institutes and Universities
Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/immunoassay-market-5841
Comprehensive Regional Analysis
The Americas dominates the immunoassay market owing to the presence of major market players, high adoption rate, and increasing prevalence of infectious diseases. According to the statistics suggested by the Centers for Disease Control (CDC) and Prevention, around 9,421 cases of tuberculosis, 51,455 cases of salmonella, 33,461 cases of Lyme disease, and 433 cases of meningococcal disease were registered in the United States. It is also reported that nearly 16.8 million individuals visit physician offices for infectious and parasitic diseases.
Europe holds the second position in the immunoassay market. It is expected that the funding provided by the government and private organizations towards research and development, along with the rising prevalence of infectious disease are likely to drive the European market.
Owing to a huge patient pool, increasing demand, and development in the healthcare technology, Asia Pacific is the fastest growing immunoassay market. Healthcare expenditure is found to be improving in various regions in Asia Pacific. According to the data suggested by the Australian Institute of Health and Welfare during the year 2015–16, the total health expenditure was USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014–2015. The increasing cases of bladder cancer are also propelling the market growth in the Asia Pacific region. According to a 2016 study published in the Journal of Translational Medicine, nearly 12,000 patients are newly diagnosed with bladder cancer, and around 5000 patients die from the disease annually in Japan. The onset of this disease is mostly seen in the more elderly population. A multiplex urinary immunoassay is commonly used for the detection of bladder cancer.
The Middle East and Africa holds the lowest share in the global immunoassay market due to low development, lack of technical knowledge, and poor medical facilities.
Avail Discount at https://www.marketresearchfuture.com/check-discount/5841
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Info:
Name: Akash Anand
Organization: Market Research Future
Address: Magarpatta Road, Hadapsar, Pune
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/press-release/immunoassay-market
Source: MarketersMedia
Release ID: 466792
More News
Analysis: Trump's shock Russia deal highlights mounting pressure to curb fuel prices
The US president hopes to ease his party's pain before next month's midterm elections, writes the BBC's North America correspondent.
Trump Announces White House Inquiry Into Fed Governor Lisa Cook
President Trump said the White House would investigate unsubstantiated claims that Lisa D. Cook committed mortgage fraud and hold a hearing next month.
Private Medicare Plans Are Raising Costs And Forcing Millions To Find New Insurance
As enrollment for Medicare Advantage begins this month, older Americans are confronting fewer options because insurers are discontinuing coverage in many areas.
Trump wants to reduce the cost of fuel as the midterms loom - will it work?
The price of fuel has soared as the cost of living emerges as a key issue for millions of Americans.
Target Says It’s Not Working With ICE Amid Uproar Over Parking Lot Use
The retailer came under attack for being a staging area for immigration officers after Thursday’s shooting in New York City.
China and Europe Step Back From Trade War With Limits on Chinese Car Exports
The European Union said the deal could roughly halve shipments of hybrid vehicles from China in the next four years. But it also could lead to an even stronger Chinese auto industry.
How Correspondent Banking Can Enable Sanctions Evasion
The correspondent system for banking has enabled globalism — and has been exploited by companies trying to skirt U.S. sanctions.
Trump Sends Obamacare ‘Refund’ Checks Ahead of Midterm Elections
The $500 checks are accompanied by a letter signed by the president that criticizes the Biden administration for overcharging Americans for health insurance.
Burnham promises to curb non-compete rules in job contracts
The prime minister says restrictions on what workers can do after leaving roles have "gone too far".
Whistle-Blower Says I.R.S. Leaked His Tax Records in Retaliation
Brian J. Visalli, a veteran investigator of tax fraud, said in a lawsuit that the agency had sent his personal and tax information to federal prosecutors.
Ex-Deutsche Bank trader jailed for rigging rates has conviction overturned
The Court of Appeal quashes the conviction of Christian Bittar, a former Deutsche Bank trader jailed in 2018.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.